Germany based Novosom has received patents for both the US and Europe for its drug Delivery technology Smarticles.
14 May 2008 2:32pm
AstraZeneca has announced that the FDA has approved Seroquel for the maintenance treatment of patients with bipolar I disorder, as adjunct to lithium or divalproex.
14 May 2008 2:31pm
The Nestle Research Center, Lausanne, Switzerland and GE Global Research, the General Electric Company's centralized research and development organization, have announced an innovative collaboration to scientifically assess associations between body composition, metabolic status, diet and lifestyle habits.
14 May 2008 2:28pm
Oncolytics Biotech has received a letter of approval from the UK Medicines and Healthcare products Regulatory Agency, for its clinical trial application to begin a Phase II clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers.
14 May 2008 2:26pm
StemCor Systems has received a National Institutes of Health Phase I Small Business Innovation Research Grant to further develop the MarrowMiner, which recently received 510(k) clearance from the FDA for harvesting bone marrow.
14 May 2008 2:23pm
Qiagen and Geneart have announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 human proteins.
14 May 2008 2:22pm
AVI BioPharma has announced that treatment of non-human primates with either the antisense drug AVI-6002 or with the antisense drug AVI-6003, resulted in a reproducible and high rate of survival in the face of an otherwise lethal infection with Ebola or Marburg virus, respectively.
14 May 2008 2:19pm
Lundbeck has launched Circadin, a new, first in class sleep medication for insomnia sufferers in Europe.
14 May 2008 2:18pm
St Jude Medical has announced the initial enrollments into a new landmark clinical trial designed to better identify which patients could benefit from implantable cardioverter defibrillator therapy for the prevention of sudden cardiac arrest.
14 May 2008 2:16pm
Medimetriks Pharmaceuticals has commenced operations. The newly-formed company will develop, license and commercialize innovative prescription products for the dermatology and podiatry marketplaces.
14 May 2008 2:13pm
Xtent has announced positive six-month follow-up data from the Custom III clinical trial, which assessed the safety and efficacy of the Custom NX drug eluting stent system for the treatment of patients with coronary artery disease.
14 May 2008 2:11pm